3 hours ago
Arrowhead Pharmaceuticals (ARWR) Stock Surges 481% — Wall Street Eyes Further Gains
Arrowhead Pharmaceuticals (ARWR) gains 3.9% after Morgan Stanley upgrade. Stock up 481% in 12 months with analysts forecasting more upside ahead.
The post Arrowhead Pharmaceuticals (ARWR) Stock Surges 481% — Wall Street Eyes Further Gains appeared first on Blockonomi.
Source: Blockonomi →Related News
- 40 minutes ago
SoundHound AI (SOUN) Stock Declines Following $43M LivePerson Acquisition Announ...
- 1 hour ago
SEALSQ Corp (LAES) Stock Climbs as AI Advances Fuel Quantum Security Demand
- 2 hours ago
Broadcom (AVGO) vs Marvell (MRVL): Which AI Chip Stock Should You Buy in 2025?
- 3 hours ago
Seagate Technology (STX) Stock Soars to Record High on 25% Revenue Surge
- 3 hours ago
Palantir (PLTR) Stock Tumbles 18% Despite Presidential Endorsement and Stellar E...